Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function

We observed minimal declines in physical function over 5 years of follow-up among middle-aged PWH, with no differences among PWH randomized to pitavastatin compared to placebo. This finding, combined with low prevalence of myalgias, supports the long-term safety of statin therapy on physical function, when used for primary prevention of major adverse cardiovascular events among PWH.

Authors

Institutions

Publication Details

Journal
Clinical Infectious Diseases
Published
2024-08-19
DOI
https://doi.org/10.1093/cid/ciae422
Citations
3
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
1.72

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function

Markella V. Zanni, Kristine Mace Erlandson, Heather J. Ribaudo, Carl J. Fichtenbaum et al.
3 citations
Clinical Infectious Diseases
Lipoproteins and Cardiovascular Health
1.72
article

Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function

Markella V. Zanni, Kristine Mace Erlandson, Heather J. Ribaudo, Carl J. Fichtenbaum, Maria C. Rodriguez‐Barradas, Edgar T. Overton, Rosalba Gomez Morones, Pamela S. Douglas, Steven Grinspoon, Todd T. Brown, Triin Umbleja, Carlos Malvestutto, Gerald S. Bloomfield, Jennifer A. Schrack, Jhoanna C. Roa, Marissa R Diggs, Kathleen V. Fitch, Judith A. Aberg, Kenneth W. Wood, K. Breaux
article en
3 citations

Abstract

We observed minimal declines in physical function over 5 years of follow-up among middle-aged PWH, with no differences among PWH randomized to pitavastatin compared to placebo. This finding, combined with low prevalence of myalgias, supports the long-term safety of statin therapy on physical function, when used for primary prevention of major adverse cardiovascular events among PWH.

Clinical Infectious DiseasesVol. 80(2)
Michael E. DeBakey VA Medical Center (US), Harvard University (US), Johns Hopkins University (US), Duke University (US), Baylor College of Medicine (US), The Ohio State University Wexner Medical Center (US), University of Alabama at Birmingham (US), Massachusetts General Hospital (US), Clinical Research Institute (US), Columbus Oncology and Hematology Associates (US), Cancer Research And Biostatistics (US), Frontier Science & Technology Research Foundation, Inc. (US), Durham VA Medical Center (US), University of Colorado Anschutz Medical Campus (US), University of Cincinnati Medical Center (US), University of Colorado Denver (US), Icahn School of Medicine at Mount Sinai (US)
Gilead Sciences, ViiV Healthcare, Norges Idrettshøgskole, Nutrition Obesity Research Center at Harvard, National Institute on Aging, National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 15%
Lipoproteins and Cardiovascular Health
1.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.